1 In rabbit polymorphonuclear leukocytes (PMNLs) apomorphine at 10-100 yM inhibits fMet-LeuPhe and A23187-induced exocytosis, and the phorbol myristate acetate-and fMet-Leu-Phe-induced activation of the metabolic burst. The secretory response was not restored by washing the cells after pretreatment with apomorphine. 2 The inhibitory effect of apomorphine was not prevented by the dopamine receptor antagonists haloperidol and pimozide, nor did dopamine itself inhibit fMet-Leu-Phe-induced exocytosis. It therefore seems unlikely that effects are mediated via dopamine receptors. However, sulphydryl reagents reduced the inhibitory effect of apomorphine, suggesting that it may depend upon interaction with susceptible sulphydryl groups, the intactness of which is required for exocytosis and other functions of PMNLs.
Introduction
Apomorphine is a well known agonist of dopamine. It causes sedation and behavioural changes in mammals and it has a therapeutic effect in some neurological and psychiatric conditions, although the emetic action of the drug prevents the use of high concentrations. These effects are thought to be due to an interaction with the dopamine receptor (Di Chiara et al., 1978) .
Recently it was found that apomorphine has an inhibitory effect on several types of secretory cells. For example it inhibits insulin secretion from rat pancreas (Joost et al., 1983) , transmitter release evoked by 5-hydroxytryptamine from the sympathetic nerves ofthe perfused rabbit heart (Carr & Fozard, 1982) , and histamine release by exocytosis from mast cells (Mietto et al., 1984; Batistella et al., 1986) .
Exocytosis is an important function ofthe polymorphonuclear leukocyte (PMNL). The granules of the PMNL contain hydrolytic and proteolytic enzymes which may contribute to the destruction of invading microorganisms or cause tissue damage in inflammatory reactions (Weissmann et al., 1980) . Exocytosis may be induced with soluble activators many ofwhich also stimulate the metabolic burst. This comprises a series of reactions, including the uptake of molecular oxygen and its conversion into toxic metabolites (Fantone & Ward, 1982) .
This report concerns a pharmacological study ofthe effect of apomorphine on exocytosis and metabolic burst in rabbit PMNLs.
Methods

Polymorphonuclear leukocytes
Rabbit peritoneal polymorphonuclear leukocytes (PMNLs) were obtained as described previously (Elferink & Deierkauf, 1987) . The cells were suspended in a medium consisting of (mM): NaCl 140, KCI 5, glucose 10 and HEPES 20, pH 7.3; 1 mM Ca2" was included in the medium, except where indicated. The final cell suspension during the experiments contained 3 x 106 PMNLs per ml.
Exocytosis
Exocytosis was measured as the release of granuleassociated enzyme lysozyme in the absence of significantly increased release of the cytoplasmic enzyme lactate dehydrogenase (LDH) . Cells were preincubated with or without apomorphine for Omin at 37°C, after which an exocytosis-inducing activator was added. After incubation for 20 min at 37°C the cells were centrifuged and enzyme release in the supernatant was measured as described previously (Elferink & Deierkauf, 1984) . LDH release, which was measured as the conversion of NADH into NAD' during the conversion of pyruvate into lactate, was always lower than 5%. Enzyme release was expressed as a percentage of the total cellular lysozyme content, wThe Macmillan Press Ltd 1987 obtained by lysing the cells with 0.2% Triton X-100. To cause exocytosis, either the combination of fMetLeu-Phe (10-SM) + cytochalasin B (5 x 10-6'M), or ionophore A23187 (5 x 10-7M) was used.
Metabolic burst
The metabolic burst was measured in terms of increased NBT reduction (Elferink, 1984) by including 0.4 mM (Nitro)B(lue)T(etrazolium) in the reaction mixture. After preincubation of the cells with or without apomorphine for 10 min at 37C an activator of the metabolic burst, fMet-Leu-Phe(l0-8M)+cyto-chalasin B (5 x 10-6 M), or phorbol myristate acetate (PMA)(l00 ng ml-'), was added, followed by incubation for 15 min at 37C. Subsequently 5 ml 0.5 M HCI was added, the mixture was centrifuged, and the residue was dissolved in 2 ml pyridine in a boiling waterbath. The absorbance of the pyridine solution was measured spectrophotometrically at 510 nm, and the results were expressed as nmol NBT reduced per 3 x I0 PMNLs per 15min.
A TP level After incubation of PMNLs with or without apomorphine or another inhibitor for 20 min at 37°C, an equal volume of ice-cold tricholoroacetic acid (10%) was added to the reaction mixture. After 10 min the solution was neutralized with sodium acetate (1.5 M) and the ATP content was determined by the luminescence technique, using luciferin-luciferase from firefly tails, as described by Strehler (1968) . In this experiment glucose was omitted from the medium.
Results
Apomorphine inhibited fMet-Leu-Phe-induced lysozyme release in the concentration range of 10-100 ILM. Neither in the absence nor in the presence of apomorphine was there significant release of LDH, indicating that lysozyme release is a direct measure of the degree of exocytosis (Figure 1 ). Ionophore A23187-induced lysozyme release was inhibited by apomorphine in a similar fashion. Similarly, apomorphine inhibited the metabolic burst induced with either fMet-Leu-Phe in the presence of cytochalasin B, or with two doses of phorbol myristate acetate (PMA) at the same concentration ( Figure 1 ). PMA was used to activate the metabolic burst, and ionophore A23187 for exocytosis, because in rabbit PMNLs, PMA is a strong activator of the metabolic burst but gives little exocytosis, whereas the reverse applies to A23187.
The inhibitory effect of apomorphine on fMet-LeuPhe-induced lysozyme release persists even if the fMet-Leu-Phe-induced lysozyme release but not of A23187-induced enzyme release (Student's t test). Inhibition of NBT reduction at this concentration was significant with fMet-Leu-Phe and phorbol myristate acetate (PMA, 5 ng ml') (P <0.005) and with PMA (100 ng ml-') (P < 0.05). Procedure A: 3 x 10' cells per ml were exposed to the indicated amount of apomorphine for 10 min at 37°C. Then activator (10-8M fMet-Leu-Phe + 5 x l0-M cytochalasin B) was added, followed by incubation for 20 min at 37°C.
Procedure B: 3 x 106 cells per ml were exposed to the indicated amount of apomorphine for 10 min at 37C. Then the mixture was centrifuged and the supernatant discarded. The pelleted cells were washed with 10 ml medium and centrifuged. The cells were resuspended in Ca2"-containing medium and activator were added to a total volume of I ml, and the mixture was incubated for 20 min at 37C Lys: lysozyme. The values given are the means of four experiments ± s.d. phine (Table 1) . Activation of washed cells in the absence of apomorphine resulted in a slightly lower lysozyme release and a higher LDH release as compared with control cells. Apomorphine is a known dopamine receptor agonist and to establish the possible involvement of this receptor in the mechanism of inhibition, the effect of dopamine and of the dopamine receptor antagonists pimozide and haloperidol were investigated. Dopamine (10-100IM) had no inhibitory effect on shifted to higher concentrations (Figure 2) . Note that the extent of inhibition of exocytosis by apomorphine is to some degree dependent on the batch of cells, as can be seen by comparison of Figures I and 2 . Because an interference with cellular metabolism could provide an explanation for the inhibitory action of apomorphine, the effect on cellular ATP level was considered. Whereas the classical inhibitors of glycolysis (2-deoxyglucose, iodoacetate and sodium fluoride) strongly reduced the ATP level of resting cells, high concentrations of apomorphine had little effect (Figure 3 ).
IA NaF
Inhibition ofexocytosis by apomorphine is substantially reduced by pretreatment of apomorphine with inhibitors of sulfphydryl compounds. In this regard glutathione Ls. Cells were was especially effective (Table 3) . (Giordano & Lichtman, 1973) ; Elferink & Riemersma, 1980; Yamashita, 1983) . The inhibitory effect of apomorphine was substantially reduced by pretreatment of the drug with compounds containing sulphydryl groups. Apparently apomorphine may act as a sulphydryl reagent. It seems likely that the inhibitory effect of apomorphine is due to its ability to react with vulnerable sulphydryl groups that are required for PMNL functions susceptible to apomorphine.
The PMNL contains in its cytoplasm a very high concentration (4mM) of glutathione (Oliver et al., 1976) which might be expected to inactivate apomorphine should it penetrate into the cell. The vulnerable sulphydryl groups involved are thus probably located on proteins of the PMNL plasma membrane.
The effect of apomorphine was also reduced in the presence of albumin. This could be related to the presence ofa sulphydryl group in albumin. Because of the high concentration of albumin in serum it is unlikely that inhibition of PMNL function by apomorphine is of importance in vivo.
